This is an email from Your Coronavirus Update, a newsletter by Medium Coronavirus Blog.

The Latest: Why cases are rising in kids

Dear Reader,

This morning, President Donald Trump shared tweets criticizing the U.S. Centers for Disease Control and Prevention’s guidelines for safely reopening schools, arguing they are impractical. The CDC’s guidance recommends standard physical distancing measures, like keeping desks apart, staggering drop-off and pick-up times, and refraining from field trips and extracurricular activities.

Trump argued that other countries like Germany, Norway, Denmark, and Sweden that have reopened schools with “no problems”. But the first three countries have gained the upper hand on Covid-19. Sweden has experienced many more deaths than neighboring countries. The United States just reported a record daily total of new cases. Scientists are also still learning about the risks of Covid-19 for children, which you can read about in detail here.

Now more than ever it’s important to listen to the scientists, who are making headway even amid political obstacles.

Here’s what’s new:

  • Cases in the U.S. hit another daily high: Coronavirus cases reached a daily record of about 60,000. Texas reported its highest one-day increase in infections so far, with over 10,000 new cases.
  • The U.S. is formally pulling out of the World Health Organization: The administration sent notice to the United Nations secretary-general, and the withdrawal will be effective July 6, 2021. Read more.
  • Brazil’s president tests positive: Jair Bolsonaro, president of Brazil, tested positive for Covid-19 after months of dismissing the danger posed by the disease. The pandemic has killed over 65,000 Brazilians.
  • U.S. will give $1.6 billion for a vaccine: The federal government will give the vaccine maker Novovax $1.6 billion to develop 100 million doses of a Covid-19 vaccine by early next year. Read more.
  • Antibody drug moves into late-stage clinical trial: A phase 3 clinical trial for REGN-COV2, an antibody treatment for Covid-19, began on Monday. Researchers hope that the drug will prevent infection among uninfected people who were exposed to the novel coronavirus.

Follow our Medium Coronavirus Blog for regular updates, and read some of the essential stories we’ve curated below.

Be well,

Alexandra Sifferlin
Editor, Medium Coronavirus Blog

Was this email forwarded to you by a friend? Sign up to receive regular updates from our Coronavirus Team in your inbox.

Sign up here 📩

New on the blog

How to Make Sense of Cases Spiking Among Young Kids

There Is a Light at the End of the Tunnel

Trump Has Quit on the Coronavirus

Masking Is Not Just a Matter of If, but What Kind and When

Essential explainers

Covid-19 May Trigger Diabetes in Otherwise Healthy People

Don’t Panic Over the ‘New’ Swine Flu You’ve Been Hearing About

How Greece Managed to Get It Right

The Irony of Falling Vaccination Rates

5 smart reads

What Covid-19 Did to My Brain

Inside a Lab Developing a Coronavirus Treatment

How ‘Social Pods’ Can Help Families Find Joy Again

The Pandemic Experts Are Not Okay (The Atlantic)

Employers Find Testing Employees More Trouble Than It’s Worth (Bloomberg)

Health and science journalist. Former editor of Medium’s Covid-19 Blog and deputy editor at Elemental. TIME Magazine writer before that